Kukjeon Pharmaceutical Co Ltd (307750)

Currency in KRW
4,015
+80(+2.03%)
Delayed Data·
307750 Scorecard
Full Analysis
High shareholder yield
307750 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
3,9404,050
52 wk Range
2,7805,350
Key Statistics
Bid/Ask
4,005.00 / 4,010.00
Prev. Close
3,935
Open
3,940
Day's Range
3,940-4,050
52 wk Range
2,780-5,350
Volume
105.69K
Average Volume (3m)
1.77M
1-Year Change
-12.12%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
307750 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Buy

Kukjeon Pharmaceutical Co Ltd Company Profile

KUKJEON PHARMACEUTICAL Co., Ltd operates as a chemical total solutions provider in South Korea. It provides various chemical-based products and services; and after-sales services, such as research and development, production, quality control, and DMF services. The company manufactures active pharmaceutical ingredients; and offers molecular design and technical support. It develops electronic materials, such as antistatic agents, monomers and polymers with low dielectric constant, and UV curing agents; low-resistance electrolyte, phosphine, silane, and boron compounds; semiconductor materials; and carbazole, boric acid, and fluorene intermediates. In addition, the company owns patents for its manufacturing methods. It serves pharmaceuticals, intermediate products, new drug synthesis, and related materials industries. The company was founded in 1972 and is headquartered in Anyang-si, South Korea.

Employees
172

Compare 307750 to Peers and Sector

Metrics to compare
307750
Peers
Sector
Relationship
P/E Ratio
136.4x7.6x−0.5x
PEG Ratio
19.440.010.00
Price/Book
2.0x0.8x2.6x
Price / LTM Sales
1.5x0.6x3.3x
Upside (Analyst Target)
-52.5%43.4%
Fair Value Upside
Unlock27.5%7.1%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 29.35%
Dividend Yield
0.25%
Industry Median 0.93%
Annualised payout
10.00
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
May 14, 2025
EPS / Forecast
18.03 / --
Revenue / Forecast
38.28B / --
EPS Revisions
Last 90 days

307750 Income Statement

People Also Watch

40,950
103590
-2.03%
1,759
003280
-0.62%
1,611
008970
+0.25%
2,240
033340
+14.05%
40,850
044490
-1.45%

FAQ

What Stock Exchange Does Kukjeon Pharmaceutical Trade On?

Kukjeon Pharmaceutical is listed and trades on the KOSDAQ stock exchange.

What Is the Stock Symbol for Kukjeon Pharmaceutical?

The stock symbol for Kukjeon Pharmaceutical is "307750."

What Is the Kukjeon Pharmaceutical Market Cap?

As of today, Kukjeon Pharmaceutical market cap is 196.62B.

What Is Kukjeon Pharmaceutical's Earnings Per Share (TTM)?

The Kukjeon Pharmaceutical EPS (TTM) is 29.35.

From a Technical Analysis Perspective, Is 307750 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Kukjeon Pharmaceutical Stock Split?

Kukjeon Pharmaceutical has split 1 times.

How Many Employees Does Kukjeon Pharmaceutical Have?

Kukjeon Pharmaceutical has 172 employees.

What is the current trading status of Kukjeon Pharmaceutical (307750)?

As of 08 Aug 2025, Kukjeon Pharmaceutical (307750) is trading at a price of 4,015.00, with a previous close of 3,935.00. The stock has fluctuated within a day range of 3,940.00 to 4,050.00, while its 52-week range spans from 2,780.00 to 5,350.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.